A review of treatment for retinopathy of prematurity

Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert review of ophthalmology Ročník 14; číslo 2; s. 73 - 87
Hlavní autoři: Hansen, Eric D., Hartnett, M. Elizabeth
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Taylor & Francis 04.03.2019
Témata:
ISSN:1746-9899, 1746-9902
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Introduction: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. Areas covered: Recent methods to identify and manage treatment-warranted vascularly active ROP are recognized and being compared to standard care by laser treatment in prospective large-scale clinical studies. Pharmacologic anti-angiogenic (anti-VEGF) treatment has changed the natural history of vascularly active ROP by reducing stage 3 intravitreal neovascularization and extending physiologic retinal vascularization in many infants. Tractional retinal detachments in stage 4 ROP after treatment with anti-VEGF agents show additional fibrovascular complexity compared to eyes treated with laser only. We review current management and outcomes for vascularly active and fibrovascular retinal detachment in ROP (stages 3, 4, 5 ROP), highlighting the evidence from recent clinical studies. Included are technical details important in surgery for retinal detachment in ROP. Literature searches were employed through PubMed. Expert opinion: Experimental studies in basic mechanisms, methods in pediatric imaging, safer pharmacologic treatments, and surgical techniques continue to advance to improve future ROP outcomes.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1746-9899
1746-9902
DOI:10.1080/17469899.2019.1596026